Received Oct 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | N/A | H4K3S | IM / RA |
Patient received a Tdap in May 2025. No adverse events witnessed after administration, only that vaccine was given too soon.
DMII, ESRD, GERD, Prostate Cancer, HLD, HPTH, Aortic Valve stenosis, Afib, HTN
Amiodarone 200mg, Apixaban 5mg, Atorvastatin 80mg, Carvedilol 12.5mg, Cinacalcet 30mg, topical Clindamycin 1%, Clopidogrel 75mg, Docusate 100mg, Vanicream, Empagliflozin 10mg, Escitalopram 5mg, Evolocumab 140mg/mL, Ezetimibe 10mg, Gabapenti
NKA
N/A